课题基金 / 基金详情

Role of ARID1A in endometrial proliferation, endometriosis and endometriosis-associated ovarian cancer pathogenesis

Role of ARID1A in endometrial proliferation, endometriosis and endometriosis-associated ovarian cancer pathogenesis
ARID1A在子宫内膜增殖、子宫内膜异位症和子宫内膜异位症相关卵巢癌发病机制中的作用
批准号:
G1001957/1
负责人:
Ioannis Gounaris
金额:
$32.52万
依托单位:
依托单位国家:
英国
项目类别:
Fellowship
财政年份:
2011
资助国家:
英国
项目状态:
已结题
起止时间:
2011 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Ovarian cancer is one of the leading causes of death from cancer in women. There are 4 major types of ovarian cancer. The clear-cell and endometrioid types of ovarian cancer are related to a condition called endometriosis. The latter is a common cause of pelvic pain and infertility. Clear-cell cancer in particular, is very difficult to treat when it has spread because currently available chemotherapies are not effective. Recent research has identified a gene, called ARID1A, which appears to play a role in these two types of ovarian cancer. Specifically, mutations of this gene are found in approximately a third of endometrioid cancers and a half of clear cell cancers as well as in endometriosis. This research project aims to find out how mutations in ARID1A cause cancer. This will involve testing the effects of the mutation on growth and hormonal control in cells cultured in a petri dish. It will also involve experiments in mice that have this gene mutation. If we are able to understand better how this mutation causes cancer, then we will be able to design better treatments that will allow these patients to live longer or have less symptoms.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
ARID1A通过调控H3K27乙酰化激活超级增强子介导肺血管内皮细胞凋亡在慢阻肺病中的机制研究
  • 批准号:
    2026JJ60290
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    成玮
  • 依托单位:
E2F1转录抑制FBXL7/PFKFB4轴在ARID1A调控肝癌糖酵解进展中的作用研究
  • 批准号:
    2026JJ80631
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    周定中
  • 依托单位:
ARID1A参与子宫内膜异位症发病机制的研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
  • 依托单位:
ARID1A活性状态对肝癌铁死亡相关代谢重编程的调控机制及精准治疗策略研究
  • 批准号:
    2024Y9611
  • 项目类别:
    省市级项目
  • 资助金额:
    50.0万元
  • 批准年份:
    2024
  • 负责人:
    陈一然
  • 依托单位: